Cyclerion Therapeutics (CYCN) Change in Cash (2019 - 2025)

Cyclerion Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at $1.6 million for Q3 2025.

• In Q3 2025, Change in Cash rose 191.03% year-over-year to $1.6 million; the TTM figure through Sep 2025 stood at $1.7 million (up 127.2% YoY), while the FY2024 annual figure was -$4.3 million, up 25.33% from the prior year.
• Change in Cash for Q3 2025 stood at $1.6 million, up from -$633000.0 in the prior quarter.
• The five-year high for Change in Cash was $25.1 million in Q2 2021, with the low at -$13.0 million in Q1 2021.
• The 5-year median for Change in Cash is -$1.7 million (2024), against an average of -$2.8 million.
• Peak annual rise in Change in Cash reached 336.24% in 2021, while the deepest fall reached 185.5% in 2021.
• Cyclerion Therapeutics' Change in Cash stood at -$8.5 million in 2021, then gained by 17.78% to -$7.0 million in 2022, then surged by 78.11% to -$1.5 million in 2023, then jumped by 123.42% to $360000.0 in 2024, then jumped by 333.89% to $1.6 million in 2025.
• Business Quant data shows CYCN's Change in Cash at $1.6 million in Q3 2025, -$633000.0 in Q2 2025, and $407000.0 in Q1 2025.